Letter to the Editor in response to the articles 'Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)' and 'Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.'

Pharmacol Res. 2021 Jan:163:105289. doi: 10.1016/j.phrs.2020.105289. Epub 2020 Nov 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Antiviral Agents* / pharmacology
  • Antiviral Agents* / therapeutic use
  • COVID-19*
  • Drugs, Chinese Herbal
  • Humans
  • NF-kappa B / metabolism
  • SARS-CoV-2
  • Signal Transduction / drug effects

Substances

  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Drugs, Chinese Herbal
  • NF-kappa B
  • lianhuaqingwen